1[1]David R, Gandara D, Martin J, et al. Current status and novel therapeutic approaches in advanced non-small-cell lung cancer. ASCO Education Book,1990,35∶362-369.
3[3]Montalar J, Morales S, Maestu I, et al. Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer. Lung Cancer,2001,34(2)∶305-311.
2[1]Chevalier TL,Brisgand D,Douillard JY,et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients[J].J Clin Oncol, 1994,12: 360 - 367.
3[2]Perng RP,Shih JF,Chen YM,et al.A phase Ⅱ trial vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer[J]. Am J Clin Oncol, 2000,23:60 - 64.
4[3]Tan EH,Ang PT,Wee J,et al. Vinorelbine,ifosfamide and cisplatin in advanced non-small cell lung cancer[J]. Acta Oncol, 1999,38: 619-622.
5[4]Rey F,Astoul P,Marqueste L,et al.Cisplatin,ifosfamide,and vinorelbine combination chemotherapy in stage Ⅲ～Ⅳ non-small-cell lung cancer: a phase Ⅱ study[J]. Am J Clin Oncol, 1998,21:518 - 522.
5Kosmidis P.Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer a phase Ⅲ randomized trial[J].J Clin Oncoi,2002,20(17):3578.
6Paccagnella A,Oniga F,Bearz A,et al.Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer:results of a phase Ⅱ-Ⅲ study[J].J Clin Oncol,2006,24(14):2220.
7Schuette W,Blankenburg T,Guschall W,et al.Multicenter randomized trial for stage ⅢB/Ⅳ non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatin[J].Clin Lung Cancer,2006,7 (5):338-343.
8Chen YM,Perng RP,Lee YC,et al.Pactitaxel plus carboplatin compared with paclitaxel plus gemcitabine shows similar efficacy while more cost-effective:a randomized phase Ⅱ study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated[J].Ann Oncol,2002,13(1):108-114.
9Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung Cancer[J].N Engl J Med,2002,346(2):92-96.
10Klauber N, Paeangi S, Flynn E, et al. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2 - methoxyestradiol and Taxal [ J ]. Cancer Res, 1997, 57 ( 1 ) : 81.
